Loading company…
Monomer Bio provides lab automation and data tools for cell culture processes.
Monomer Bio provides automation for cell culture processes involving stem cells, primary cells, and immortalized cells. Its platform collects and organizes culture data and supports machine learning for cell health assessment. Founded in 2021 and based in Pacifica, US, the company raised USD 5.6 million in seed funding in January 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in